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complications (fatal or non-fatalmajor stroke,minor stroke, PRIND, TIA
or death) was 10.1% in group 1 and 6.7% in group 2 (p¼0.042). After the
introduction of cerebral protection devices in April 2004, a signiﬁcant
reduction of the complication could be observed in all patients (11.1%
without and 6.5% with protection). With respect to the two groups
deﬁned above, reduction was signiﬁcant in group 1 (14.8% without and
7.1% with protection device [p¼0.003]) whereas in group 2 only a pos-
itive trend from 7.8% to 6,0% (p¼0.402) could be found.
CONCLUSIONS There are different peri-interventional complication
rates in pts undergoing CAS depending on the vessel treated. The
more complex anatomical situation at the origin of the left carotid
artery might result in a more frequent mobilization of intraluminal
plaque components from the aorta or the truncus brachiocephalicus.
The signiﬁcant reduction of cerebrovascular events when using ﬁlter
devices corroborates this hypothesis.
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BACKGROUND Instent- restenosis is a major issue after all intravascular
interventional treatments applying stents. We retrospectively analyzed
data from our center with respect to instent-restenosis rates in patients
who had undergone carotid artery stenting (CAS) at our department.
METHODS We retrospectively analyzed 1137 consecutive patients
(pts) with a mean age of 71.7  38.6 years who had undergone 1150
interventional procedures of the carotid arteries at our institution
between December 1997 and January 2015,. Post-interventional
routine follow-up with an ultrasound examination was scheduled at
one as well as six months after the procedure and after that on a yearly
basis. Signiﬁcant instent-restenosis was deﬁned as a lumen narrowing
>50% within the stent as assessed by Doppler velocities of more than
200 cm/second. Patients were divided into two groups with respect to
the stents used. 462 stenoses (40.2%) were treated with balloon-
expandable stents (group 1), whereas the remaining 688 stenoses
(59.8%) were treated with self-expandable stents (group 2).
RESULTS Long term follow-up with a mean duration of 38 months
showed an instent-restenoses rate of 6.8% (78 pts) for the entire cohort. In
group 1, instent-restenoses occurred in 54 pts (11.7%), in group 2, in 24 pts
(3.5%; p<0.001 for between group difference). Initial post-dilatation was
performed in 81 pts (17.5%) in group 1 but in 564 pts (82.0%) in group 2
(p<0.001). We found post-dilatation to signiﬁcantly decrease the in
instent-restenosis rate in group 1 (post-dilatation vs. no post-dilatation:
p¼0.037), but not in group 2 (post-dilatation vs. no post-dilatation:
p¼0.860). In group 2, no differencewas found between patientswhowere
treated with tapered or non-tapered stents (p¼0.114), respectively.
CONCLUSIONS Instent-restenoses >50% after CAS occurred infre-
quently during long term follow-up (6.8%) in our cohort. This state-
ment held true especially for those patients who had been treated
with self-expandable stents (3.5%). In patients who had been treated
with balloon-expandable stents, post-dilatation reduced instent-
restenoses signiﬁcantly. The shape of self-expandable stents did not
inﬂuence the instent-restenosis rate.
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BACKGROUND Recently transradial (TR) approach became a safe and
effective alternative of percutaneous carotid intervention (CI). Wereport the learning curve over 5 years in two high-volume interven-
tional centers during the transition from transfemoral (TF) to trans-
radial approach.
METHODS Between 2010 and 2014, 1541 patients underwent CI in our
centers. Clinical characteristics, radiation doses, volume of contrast
material, screening and procedure times of consecutive patients were
recorded prospectively in a register and restrospectively analyzed.
RESULTS Transradial approach was applied in 323 patients, mean age
was 686 years, 66% of them was male. The ratio of TR has grown
from 3 to 7, 25, 43 and 48% of the CIs, during the years respectively.
While the duration of the procedure (22.5 vs. 26 min, p¼0.016), the
ﬂuoroscopy time (7.4 vs. 9.7 min, p<0.001) and the applied contrast
material (90 vs. 128 ml, p<0.001) has signiﬁcantly decreased. How-
ever, these parameters were independent of the type of the aortic
arch. Conversion to TF was needed in 8.9% and remained stable. No
difference was observed in the incidence of minor or major vascular
events and hospitalization days, over the years.
CONCLUSIONS There was an initial learning curve for ﬂuoroscopy
time, contrast material. The change from TF to TR approach is
achievable in 5 years in high-volume centers.
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BACKGROUND Ischemic stroke is a dreaded complication feared by
patients (pts) with atrial ﬁbrillation (AF). The CHADS2 & CHA2DS2-
VASc scores are the gold standard for stroke risk stratiﬁcation in AF
pts; larger scores indicate higher risk of developing stroke and guide
anticoagulation strategy. This study evaluates CHADS2 and CHA2DS2-
VASc Scores in patients at the time of presentation with stroke.
METHODS We queried the institutional stroke data base in collaboration
with the stroke service to identify all pts with AF who presented with an
acute stroke. 86 consecutive pts with AF who presented with an acute
stroke to an urban teaching hospital between 2011-2014 were analyzed.
RESULTS 46 pts (53.5%) were women and 40 pts (46.5%) were men,
with mean age 77.311.2 years; 50 pts had persistent AF, 30 pts had
paroxysmal AF, and 6 pts had new onset AF. Hypertension and
obstructive sleep apnea were present in 93% and 4.7%, respectively.
Only 2 pts (1.2 %) had a CHADS2 score >5; the score was 0-1 in 8 pts
(9.3%). CHA2DS2-VASc score was low-intermediate risk (3-5) in 72.1%
and only 16.3% pts had a score > 5. The graphs show that the largest
incidence of stroke occurred in pts with low to intermediate risk
scores, not high risk. Warfarin was the prescribed anticoagulant in 31
pts, while only 3, 2, and 1 pts respectively were taking rivaroxaban,
dabigatran, and apixaban. The INR at the time of stroke for pts on
warfarin was therapeutic in 6 pts, sub-therapeutic in 20 pts, and su-
per-therapeutic in 5 pts. Reasons for the absence of anticoagulation in
the other 49 pts included non-compliance, bleeding history, high fall
risk, perioperative condition, physician decision, and patient refusal.
